Spencer Hawkswell, TheraPsil

  • Post category:Interview

We spoke to Spencer Hawkswell, Executive Director of TheraPsil: a non-profit advocacy group seeking to facilitate legal access to psilocybin therapy for terminally-ill patients.

Continue Reading Spencer Hawkswell, TheraPsil

JR Rahn, MindMed

  • Post category:Interview

We spoke to JR Rahn, Co-Founder, Director & Co-CEO of MindMed. We asked JR about his Company's clinical trials, how COVID-19 has affected their operations, and their plans for the…

Continue Reading JR Rahn, MindMed

Alex Speiser, Orthogonal Thinker

  • Post category:Interview

We spoke to Alex Speiser, COO of Orthogonal Thinker: a Company with holdings including psychedelic science business Ei.Ventures. Having already raised $6m, Orthogonal is now fundraising once more to move…

Continue Reading Alex Speiser, Orthogonal Thinker

Ashley Lukens, Ei Foundation

  • Post category:Interview

As our readers know, Psilocybin Alpha is primarily geared towards providing resources to those looking to invest in the emergent psychedelic sector. This interview is a slight detour from the…

Continue Reading Ashley Lukens, Ei Foundation

Interview with Timothy Ko, CEO, Entheon

  • Post category:Interview

Having just closed a successful raise, we spoke to Timothy Ko about Entheon's plans for the near future, and the challenges his team may face. PA: What's your personal story…

Continue Reading Interview with Timothy Ko, CEO, Entheon

Interview with Dr. Evan Wood, CMO at Numinus

  • Post category:Interview

Yesterday, Dr. Evan Wood was appointed as Chief Medical Officer of Numinus (TSXV:NUMI). Dr. Wood has an extensive bibliography of published research and has held a suite of positions across…

Continue Reading Interview with Dr. Evan Wood, CMO at Numinus